A heavy additional burden in th emanagement of Controlled Drugs might result in community pharmacists choosing not to stock them, according to the National Pharmaceutical Association. And this would not be beneficial to patients. The NPA madeits views clear to the Shipman Inquiry in advance of a consultation on the use of CDs (PJ, 9 August, p 171).
展开▼